Gabapentin NDC 17856-0600

NDC codes

FDA NDC Directory

Product NDC (as listed)17856-0600Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17856-0600Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
17856-0600-1	17856060001	72 CUP, UNIT-DOSE in 1 BOX (17856-0600-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-0600-4)Marketed from May 7, 2024
17856-0600-2	17856060002	72 CUP, UNIT-DOSE in 1 BOX (17856-0600-2) / 6 mL in 1 CUP, UNIT-DOSE (17856-0600-5)Marketed from May 7, 2024
17856-0600-7	17856060007	5 BOX, UNIT-DOSE in 1 SYRINGE (17856-0600-7) / 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0600-3) / 2 mL in 1 SYRINGE (17856-0600-6)Marketed from May 7, 2024
17856-0600-8	17856060008	60 SYRINGE in 1 BOX, UNIT-DOSE (17856-0600-8) / 2 mL in 1 SYRINGE (17856-0600-9)Marketed from Feb 5, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 250 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: ATLANTIC BIOLOGICALS CORP.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076403
Marketing start: Jun 29, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 17856-0600_361f9f34-f186-da49-e063-6394a90a3d51SPL ID 361f9f34-f186-da49-e063-6394a90a3d51SPL set ID 5969f1a8-d6d5-4967-add5-4e2492354d7bRxCUI 283523UNII 6CW7F3G59X

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N417856060001 followed by a unit qualifier and the quantity

Package 17856-0600-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 27, 2025.

Indications (excerpt from the label)

Gabapentin Oral Solution is indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin Oral Solution is indicated for: Postherpetic neuralgia in adults ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076403

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076403
Product	Strength	Form · route	Labeler	Product NDC
Gabapentin	Gabapentin 250 mg/5mL	SolutionOral	Acella Pharmaceuticals, LLC	42192-608
Gabapentin	Gabapentin 250 mg/5mL	SolutionOral	Bryant Ranch Prepack	72162-1318